Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM53B antisense RNA 1 (FAM53B-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the FAM53B locus. It is classified as an antisense RNA and like other antisense lncRNAs, may have regulatory roles in gene expression, potentially by influencing its sense counterpart (FAM53B) through transcriptional interference, chromatin modification, or stabilization/destabilization of sense mRNA[2][3]. No direct evidence currently links FAM53B-AS1 to specific biological pathways, diseases, or therapeutic targeting. Its gene is cataloged in multiple databases under the aliases listed above[3]. While the FAM53B sense gene plays a role in transcriptional regulation, cell proliferation, and the Wnt signaling pathway (notably in leukemia), there is no published functional characterization or disease association specific to the antisense transcript FAM53B-AS1[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM53B antisense RNA 1 (FAM53B-AS1).